The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer

Background:Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of earl...